For Research Purposes Only — Not for Human Consumption
Tirzepatide Oral Capsules 5mg x30
About this compound
Tirzepatide oral capsules, 5mg per capsule, 30-count bottle. Oral dual GIP/GLP-1 co-agonist formulation for metabolic research investigating incretin receptor pharmacology via the enteric route. Used in preclinical models studying oral peptide bioavailability and combinatorial incretin effects on energy homeostasis. For laboratory research only.
Minimum 2 qty required ($198.00 total)
Accepted Payment Methods
This product is intended strictly for laboratory and in-vitro research. It has not been evaluated by the FDA and is not approved for human consumption, therapeutic use, or veterinary application. Always consult primary peer-reviewed literature and a qualified professional before drawing conclusions about any compound.
Capsules
